Your browser doesn't support javascript.
loading
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Bertran-Alamillo, Jordi; Giménez-Capitán, Ana; Román, Ruth; Talbot, Sara; Whiteley, Rebecca; Floc'h, Nicolas; Martínez-Pérez, Elizabeth; Martin, Matthew J; Smith, Paul D; Sullivan, Ivana; Terp, Mikkel G; Saeh, Jamal; Marino-Buslje, Cristina; Fabbri, Giulia; Guo, Grace; Xu, Man; Tornador, Cristian; Aguilar-Hernández, Andrés; Reguart, Noemí; Ditzel, Henrik J; Martínez-Bueno, Alejandro; Nabau-Moretó, Núria; Gascó, Amaya; Rosell, Rafael; Pease, J Elizabeth; Polanska, Urszula M; Travers, Jon; Urosevic, Jelena; Molina-Vila, Miguel A.
Afiliação
  • Bertran-Alamillo J; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain.
  • Giménez-Capitán A; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain.
  • Román R; Laboratory of Oncology, Pangaea Oncology, Quiron Dexeus University Hospital, C/ Sabino Arana 5-19, 08913, Barcelona, Spain.
  • Talbot S; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Whiteley R; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Floc'h N; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Martínez-Pérez E; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina.
  • Martin MJ; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Smith PD; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Sullivan I; Servicio de Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain.
  • Terp MG; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.
  • Saeh J; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark.
  • Marino-Buslje C; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA.
  • Fabbri G; Bioinformatics Unit, Fundación Instituto Leloir, Buenos Aires, C1405BWE, Argentina.
  • Guo G; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA.
  • Xu M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA.
  • Tornador C; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, 02451, USA.
  • Aguilar-Hernández A; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain.
  • Reguart N; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.
  • Ditzel HJ; Thoracic Oncology Unit, Department of Medical Oncology, Hospital Clínic, Barcelona, 08036, Spain.
  • Martínez-Bueno A; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense C, 5000, Denmark.
  • Nabau-Moretó N; Department of Oncology, Odense University Hospital, Odense, 5000, Denmark.
  • Gascó A; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.
  • Rosell R; Teresa Moretó Foundation and Wholegenix SL, Barcelona, 08021, Spain.
  • Pease JE; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.
  • Polanska UM; Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, Barcelona, 08028, Spain.
  • Travers J; Germans Trias i Pujol Research Institute (IGTP), Badalona, 08916, Spain.
  • Urosevic J; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
  • Molina-Vila MA; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, CB21 6GH, UK.
Mol Cancer ; 22(1): 110, 2023 07 13.
Article em En | MEDLINE | ID: mdl-37443114
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Serina-Treonina Quinases / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha